Week 7 Flashcards

(31 cards)

1
Q

What is a systematic review (SR)?

A

A structured, transparent review that answers a focused research question by systematically searching, selecting, appraising, and synthesising all relevant primary studies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why are SRs near the top of the evidence pyramid?

A

They reduce bias via pre-defined protocols (e.g., PRISMA-P), combine multiple studies, and provide an objective summary for practice and policy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List three key strengths of SRs.

A

(i) Reduced bias, (ii) increased statistical power when pooled, (iii) time-efficient synthesis for clinicians.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List three main weaknesses of SRs.

A

(i) Publication bias, (ii) heterogeneity between studies, (iii) “garbage in–garbage out” if included studies are poor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name two checklist items you look for when critically evaluating an SR.

A

Clear question & eligibility criteria, comprehensive search strategy, risk-of-bias assessment, transparent synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What distinguishes a meta-analysis (MA) from a systematic review?

A

MA is the statistical pooling of effect sizes from studies (usually within an SR) to generate a precise summary estimate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give two strengths of MAs.

A

(i) Greater statistical power & narrower CIs, (ii) resolves conflicting results by providing a weighted average.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give two weaknesses of MAs.

A

(i) Susceptible to publication bias, (ii) heterogeneity (“apples vs oranges”) can mislead if studies are too diverse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What statistical tool quantifies heterogeneity in a MA?

A

I² statistic (0–100 %); higher values indicate greater between-study variability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are observational studies?

A

Non-interventional designs that observe exposures/outcomes in real-world settings to explore associations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name the three main types of observational study.

A

Cohort, case-control, and cross-sectional.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contrast prospective vs retrospective designs.

A

Prospective: follow subjects forward from exposure to outcome; Retrospective: look backward after outcome occurred.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Two key strengths of observational studies.

A

Ethical for harmful exposures; high external validity (real-world).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Two major weaknesses of observational studies.

A

Vulnerable to confounding & bias; unable to prove causation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What protocol items minimise bias in observational studies?

A

Rigorous participant selection, clear exposure/outcome definitions, statistical adjustment for confounders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Primary purpose of an RCT.

A

To test efficacy/safety of an intervention while minimising bias through randomisation and blinding.

17
Q

Three blinding levels in RCTs.

A

Single-blind (participants), double-blind (participants + researchers), triple-blind (participants + researchers + analysts).

18
Q

One strength and one weakness of RCTs.

A

Strength: strongest causal evidence; Weakness: costly and may lack real-world generalisability.

19
Q

Strengths & weaknesses of a systematic review

A

Strengths: reduces bias, increases power, broad generalisability, clear clinical guidance.
Weaknesses: publication bias, heterogeneity, depends on primary study quality, time-consuming

20
Q

Critical appraisal of an SR – key considerations

A

Focused question (PICO/PCC)

Comprehensive multi-database search (+ grey literature)

Explicit inclusion/exclusion criteria

Risk-of-bias assessment (e.g., ROBIS)

Transparent synthesis & limitations reporting

21
Q

Strengths & weaknesses of a meta-analysis

A

Strengths: higher precision, detects small effects, resolves study disagreement, hypothesis generation.
Weaknesses: sensitive to publication bias; heterogeneity; quality of pooled studies; requires advanced stats.

22
Q

Critical appraisal of a meta-analysis

A

Same items as SR plus:
* Assessment of publication bias (funnel plot, Egger test)
* Exploration of heterogeneity (I², subgroup/meta-regression)
* Appropriate model choice (fixed vs random effects)
* Sensitivity analyses reported

23
Q

Differences between scoping and narrative reviews

A

Scoping review: maps breadth of literature, identifies gaps, uses systematic search but usually no critical appraisal.

Narrative review: broad, author-driven overview; flexible search, may lack explicit methods.

24
Q
  1. Review components to check
A

Review question clarity

Sources searched (databases, grey lit)

Selection criteria pre-specified & transparent

Data evaluation tools (risk-of-bias, quality scores)

Implications for practice explicitly stated

25
7. Use of an RCT
To establish cause–effect relationships for an intervention under controlled conditions.
26
RCT strengths & weaknesses
Strengths: randomisation minimises confounding; blinding reduces bias; gold-standard for efficacy. Weaknesses: costly, ethical limits, strict criteria reduce generalisability, adherence issues.
27
9. Three types of blinding in an RCT
Single, double, triple (definitions in Flashcard 17).
28
11. Critical appraisal points for observational studies
Clear exposure/outcome definitions Temporal relationship demonstrated (esp. prospective) Control of confounders (stratification, multivariable models) Bias assessment (selection, recall, observer) Adequate follow-up (cohort)
29
12. Three types of observational study
Cohort: follow exposed & unexposed groups forward. Case-control: start with outcome, look back for exposure. Cross-sectional: assess exposure & outcome at a single time-point.
30
13. Critically appraise provided articles
Use above appraisal checklists—evaluate design appropriateness, bias control, sample size, exposure/outcome validity, statistical adjustment, and consistency of conclusions with data.
31